— Know what they know.
Not Investment Advice

ASXC AMEX

Asensus Surgical, Inc.
1W: +24.2% 1M: +2.7% 3M: +40.3% 1Y: +24.8% 3Y: -83.3% 5Y: -97.3%
$0.35
Last traded 2024-08-21 — delisted
AMEX · Healthcare · Medical - Devices · $94.9M mcap · 246M float · 1.25% daily turnover

Balance Sheet Trends

Total Assets
$61M -47.8% ▼
5Y CAGR: -24.0%
Total Liabilities
$27M +65.3% ▲
5Y CAGR: -17.5%
Shareholders Equity
$33M -66.5% ▼
5Y CAGR: -27.6%
Cash & Investments
$21M -70.1% ▼
5Y CAGR: -22.0%
Total Debt
$6M +2.6% ▲
5Y CAGR: -27.8%
Net Debt
-$11M -1343.0% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2019FY2020FY2021FY2022FY2023
— Assets —
Cash$10M$16M$18M$6M$17M
Short-Term Investments$0$0$80M$64M$4M
Cash & ST Investments$10M$16M$98M$71M$21M
Net Receivables$620K$1M$749K$2M$4M
Inventory$11M$10M$9M$8M$7M
Other Current Assets$7M$3M$2M$2M$5M
Total Current Assets$28M$34M$113M$87M$36M
Property, Plant & Equip.$5M$10M$16M$14M$14M
Goodwill & Intangibles$31M$22M$10M$2M$1M
Long-Term Investments$969K$1M$37M$4M$2M
Other Non-Current Assets$4M$10M$9M$9M$6M
Total Non-Current Assets$47M$44M$73M$29M$24M
Total Assets$75M$78M$186M$116M$61M
— Liabilities —
Accounts Payable$4M$2M$3M$3M$4M
Short-Term Debt$0$1M$0$0$1M
Deferred Revenue$818K$789K$543K$465K$421K
Other Current Liabilities$8M$5M$4M$5M$5M
Total Current Liabilities$13M$10M$10M$10M$13M
Long-Term Debt$0$2M$0$0$0
Other Non-Current Liab.$5M$4M$2M$1M$8M
Total Non-Current Liabilities$6M$6M$7M$6M$14M
Total Liabilities$19M$17M$17M$16M$27M
— Equity —
Common Stock$21K$116K$235K$237K$265K
Retained Earnings-$664M-$723M-$785M-$861M-$939M
Accumulated OCI-$1M$3M-$264K-$2M-$612K
Total Stockholders Equity$56M$62M$169M$100M$33M
Total Liabilities & Equity$75M$78M$186M$116M$61M
— Key Metrics —
Total Debt$1M$4M$6M$6M$6M
Net Debt-$8M-$12M-$12M-$791K-$11M
Total Investments$969K$1M$118M$68M$6M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms